Chapter 52: Antineoplastic Drugs Part 1: Cancer Overview and Cell Cycle–Specific Drugs

0.0(0)
Studied by 0 people
call kaiCall Kai
Locked
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/21

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 6:06 AM on 4/30/24
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai
Chat

No analytics yet

Send a link to your students to track their progress

22 Terms

1
New cards

Cancer

A group of diseases characterized by cellular transformation, uncontrolled cellular growth, invasion into surrounding tissue, and metastasis to distant organs.

2
New cards

Metastasis

The spreading of cancer from the original site to a new part of the body.

3
New cards

Benign Tumour

A tumour with uniform size and shape that does not invade other tissues or metastasize.

4
New cards

Malignant Neoplasms

Cancer cells that invade surrounding tissues and metastasize to other organs.

5
New cards

Cell Growth Cycle

Normal cells divide in a controlled manner; chemotherapy is effective in rapidly dividing tumours.

6
New cards

Antineoplastic Drugs

Medications used to treat cancer, also known as cytotoxic chemotherapy.

7
New cards

Chemotherapy

Pharmacological treatment of cancer using antineoplastic drugs.

8
New cards

Antimetabolites

Cell cycle-specific drugs that antagonize key cellular metabolites.

9
New cards

Mitotic Inhibitors

Drugs that work during mitosis to retard cell division.

10
New cards

Topoisomerase II Inhibitors

Drugs that cause breaks in DNA strands by inhibiting the enzyme topoisomerase II.

11
New cards

Topoisomerase I Inhibitors

Drugs that inhibit proper DNA function in the S phase by binding to the DNA-topoisomerase I complex.

12
New cards

Antineoplastic Enzymes

Enzymes used for the treatment of acute lymphocytic leukemia.

13
New cards

Nursing Process

Assessment and care considerations for patients receiving chemotherapy.

14
New cards

Stomatitis Management

Various interventions may be recommended for the treatment of stomatitis, such as oral hygiene practices, using soft-bristle toothbrushes, and avoiding certain foods and substances.

15
New cards

Oral Hygiene

Instructing the patient to maintain oral cleanliness by brushing before and after meals, using soft-bristle toothbrushes, and cleaning dentures regularly.

16
New cards

Stimulating Saliva Flow

Recommending the use of sugarless candy or gum to help stimulate saliva production and keep the lips moist.

17
New cards

Antifungal Treatment

Oral antifungal suspensions may be prescribed to address white patches on the oral mucosa.

18
New cards

Nausea and Vomiting Management

Educating patients on strategies to enhance comfort during nausea and vomiting episodes, including slow breathing, small frequent meals, and clear liquids.

19
New cards

Infection Risk

Patients with leukopenia or immunosuppression are at risk of infections and should be cautious around individuals with infections or recent vaccinations.

20
New cards

Reproductive Tract Effects

Informing patients about the potential negative impact of antineoplastics on the reproductive tract, including damage to the testes, ovaries, and potential teratogenic effects.

21
New cards

GI Adverse Effects

GI adverse effects may occur around the fourth day of treatment, necessitating preplanning for pharmacological and nonpharmacological interventions.

22
New cards

Therapeutic Responses

Monitoring for therapeutic responses such as clinical improvement, tumor size reduction, and decreased metastatic spread during treatment.